 | • レポートコード：QYR9ST02891 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の胃腸癌治療薬市場について調査・分析し、以下の構成でお届け致します。胃腸癌治療薬の種類別には、腫瘍学、放射線学、その他に、用途別には、病院、癌専門治療センター、クリニック、外来手術センターに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別胃腸癌治療薬売上データ ・地域別胃腸癌治療薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別胃腸癌治療薬市場規模：腫瘍学、放射線学、その他 ・用途別胃腸癌治療薬市場規模：病院、癌専門治療センター、クリニック、外来手術センター ・主要メーカーの企業情報：Amgen Limited & Amgen Ireland Limited、Bristol-Myers Squibb Company、F. Hoffmann-La Roche Ltd.、Eli Lilly and Company、Johnson & Johnson Private Limited、GlaxoSmithKline plc.、Celgene Corporation、Pfizer Inc.、Sanofi、Novartis AG ・胃腸癌治療薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems.The global Gastrointestinal Cancer Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Gastrointestinal Cancer Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Gastrointestinal Cancer Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Gastrointestinal Cancer Drugs in these regions.
This research report categorizes the global Gastrointestinal Cancer Drugs market by top players/brands, region, type and end user. This report also studies the global Gastrointestinal Cancer Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Amgen Limited & Amgen Ireland Limited
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
Johnson & Johnson Private Limited
GlaxoSmithKline plc.
Celgene Corporation
Pfizer Inc.
Sanofi
Novartis AG
Market size by Product
Oncology
Radiology
Others
Market size by End User
Hospitals
Specialized Cancer Treatment Centers
Clinics
Ambulatory Surgical Centers
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Gastrointestinal Cancer Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Gastrointestinal Cancer Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Gastrointestinal Cancer Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Gastrointestinal Cancer Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Gastrointestinal Cancer Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Gastrointestinal Cancer Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Gastrointestinal Cancer Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Gastrointestinal Cancer Drugs Market Size Growth Rate by Product
1.4.2 Oncology
1.4.3 Radiology
1.4.4 Others
1.5 Market by End User
1.5.1 Global Gastrointestinal Cancer Drugs Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Specialized Cancer Treatment Centers
1.5.4 Clinics
1.5.5 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gastrointestinal Cancer Drugs Market Size
2.1.1 Global Gastrointestinal Cancer Drugs Revenue 2014-2025
2.1.2 Global Gastrointestinal Cancer Drugs Sales 2014-2025
2.2 Gastrointestinal Cancer Drugs Growth Rate by Regions
2.2.1 Global Gastrointestinal Cancer Drugs Sales by Regions
2.2.2 Global Gastrointestinal Cancer Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Gastrointestinal Cancer Drugs Sales by Manufacturers
3.1.1 Gastrointestinal Cancer Drugs Sales by Manufacturers
3.1.2 Gastrointestinal Cancer Drugs Sales Market Share by Manufacturers
3.1.3 Global Gastrointestinal Cancer Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Gastrointestinal Cancer Drugs Revenue by Manufacturers
3.2.1 Gastrointestinal Cancer Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Gastrointestinal Cancer Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Gastrointestinal Cancer Drugs Price by Manufacturers
3.4 Gastrointestinal Cancer Drugs Manufacturing Base Distribution, Product Types
3.4.1 Gastrointestinal Cancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gastrointestinal Cancer Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Gastrointestinal Cancer Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Gastrointestinal Cancer Drugs Sales by Product
4.2 Global Gastrointestinal Cancer Drugs Revenue by Product
4.3 Gastrointestinal Cancer Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Gastrointestinal Cancer Drugs Breakdown Data by End User
6 North America
6.1 North America Gastrointestinal Cancer Drugs by Countries
6.1.1 North America Gastrointestinal Cancer Drugs Sales by Countries
6.1.2 North America Gastrointestinal Cancer Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Gastrointestinal Cancer Drugs by Product
6.3 North America Gastrointestinal Cancer Drugs by End User
7 Europe
7.1 Europe Gastrointestinal Cancer Drugs by Countries
7.1.1 Europe Gastrointestinal Cancer Drugs Sales by Countries
7.1.2 Europe Gastrointestinal Cancer Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Gastrointestinal Cancer Drugs by Product
7.3 Europe Gastrointestinal Cancer Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Gastrointestinal Cancer Drugs by Countries
8.1.1 Asia Pacific Gastrointestinal Cancer Drugs Sales by Countries
8.1.2 Asia Pacific Gastrointestinal Cancer Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Gastrointestinal Cancer Drugs by Product
8.3 Asia Pacific Gastrointestinal Cancer Drugs by End User
9 Central & South America
9.1 Central & South America Gastrointestinal Cancer Drugs by Countries
9.1.1 Central & South America Gastrointestinal Cancer Drugs Sales by Countries
9.1.2 Central & South America Gastrointestinal Cancer Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Gastrointestinal Cancer Drugs by Product
9.3 Central & South America Gastrointestinal Cancer Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Gastrointestinal Cancer Drugs by Countries
10.1.1 Middle East and Africa Gastrointestinal Cancer Drugs Sales by Countries
10.1.2 Middle East and Africa Gastrointestinal Cancer Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Gastrointestinal Cancer Drugs by Product
10.3 Middle East and Africa Gastrointestinal Cancer Drugs by End User
11 Company Profiles
11.1 Amgen Limited & Amgen Ireland Limited
11.1.1 Amgen Limited & Amgen Ireland Limited Company Details
11.1.2 Company Business Overview
11.1.3 Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drugs Products Offered
11.1.5 Amgen Limited & Amgen Ireland Limited Recent Development
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Company Business Overview
11.2.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Products Offered
11.2.5 Bristol-Myers Squibb Company Recent Development
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Company Details
11.3.2 Company Business Overview
11.3.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drugs Products Offered
11.3.5 F. Hoffmann-La Roche Ltd. Recent Development
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Details
11.4.2 Company Business Overview
11.4.3 Eli Lilly and Company Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Eli Lilly and Company Gastrointestinal Cancer Drugs Products Offered
11.4.5 Eli Lilly and Company Recent Development
11.5 Johnson & Johnson Private Limited
11.5.1 Johnson & Johnson Private Limited Company Details
11.5.2 Company Business Overview
11.5.3 Johnson & Johnson Private Limited Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Johnson & Johnson Private Limited Gastrointestinal Cancer Drugs Products Offered
11.5.5 Johnson & Johnson Private Limited Recent Development
11.6 GlaxoSmithKline plc.
11.6.1 GlaxoSmithKline plc. Company Details
11.6.2 Company Business Overview
11.6.3 GlaxoSmithKline plc. Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 GlaxoSmithKline plc. Gastrointestinal Cancer Drugs Products Offered
11.6.5 GlaxoSmithKline plc. Recent Development
11.7 Celgene Corporation
11.7.1 Celgene Corporation Company Details
11.7.2 Company Business Overview
11.7.3 Celgene Corporation Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Celgene Corporation Gastrointestinal Cancer Drugs Products Offered
11.7.5 Celgene Corporation Recent Development
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Details
11.8.2 Company Business Overview
11.8.3 Pfizer Inc. Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Pfizer Inc. Gastrointestinal Cancer Drugs Products Offered
11.8.5 Pfizer Inc. Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Company Business Overview
11.9.3 Sanofi Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Sanofi Gastrointestinal Cancer Drugs Products Offered
11.9.5 Sanofi Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Company Details
11.10.2 Company Business Overview
11.10.3 Novartis AG Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Novartis AG Gastrointestinal Cancer Drugs Products Offered
11.10.5 Novartis AG Recent Development
12 Future Forecast
12.1 Gastrointestinal Cancer Drugs Market Forecast by Regions
12.1.1 Global Gastrointestinal Cancer Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Gastrointestinal Cancer Drugs Revenue Forecast by Regions 2019-2025
12.2 Gastrointestinal Cancer Drugs Market Forecast by Product
12.2.1 Global Gastrointestinal Cancer Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Gastrointestinal Cancer Drugs Revenue Forecast by Product 2019-2025
12.3 Gastrointestinal Cancer Drugs Market Forecast by End User
12.4 North America Gastrointestinal Cancer Drugs Forecast
12.5 Europe Gastrointestinal Cancer Drugs Forecast
12.6 Asia Pacific Gastrointestinal Cancer Drugs Forecast
12.7 Central & South America Gastrointestinal Cancer Drugs Forecast
12.8 Middle East and Africa Gastrointestinal Cancer Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gastrointestinal Cancer Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Gastrointestinal Cancer Drugs Product Picture
Table Gastrointestinal Cancer Drugs Market Segments
Table Key Manufacturers Gastrointestinal Cancer Drugs Covered
Table Global Gastrointestinal Cancer Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Gastrointestinal Cancer Drugs Sales Market Share by Product 2014-2025
Figure Oncology Product Picture
Table Major Manufacturers of Oncology
Figure Radiology Product Picture
Table Major Manufacturers of Radiology
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Gastrointestinal Cancer Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Specialized Cancer Treatment Centers
Figure Clinics
Figure Ambulatory Surgical Centers
Figure Gastrointestinal Cancer Drugs Report Years Considered
Figure Global Gastrointestinal Cancer Drugs Market Size 2014-2025 (Million US$)
Figure Global Gastrointestinal Cancer Drugs Sales 2014-2025 (K Units)
Table Global Gastrointestinal Cancer Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Gastrointestinal Cancer Drugs Sales by Regions 2014-2019 (K Units)
Table Global Gastrointestinal Cancer Drugs Sales Market Share by Regions 2014-2019
Figure Global Gastrointestinal Cancer Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Gastrointestinal Cancer Drugs Sales Market Share by Regions
Table Global Gastrointestinal Cancer Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Gastrointestinal Cancer Drugs Revenue Market Share by Regions 2014-2019
Figure Global Gastrointestinal Cancer Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Gastrointestinal Cancer Drugs Revenue Market Share by Regions
Table Global Gastrointestinal Cancer Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Gastrointestinal Cancer Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Gastrointestinal Cancer Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Gastrointestinal Cancer Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Gastrointestinal Cancer Drugs Revenue Share by Manufacturers (2014-2019)
Figure Gastrointestinal Cancer Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Gastrointestinal Cancer Drugs Price (2014-2019) (USD/Unit)
Table Gastrointestinal Cancer Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Gastrointestinal Cancer Drugs Product Type
Table Date of International Manufacturers Enter into Gastrointestinal Cancer Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Gastrointestinal Cancer Drugs Sales by Product (2014-2019) (K Units)
Table Global Gastrointestinal Cancer Drugs Sales Share by Product (2014-2019)
Figure Global Gastrointestinal Cancer Drugs Sales Market Share by Product (2014-2019)
Figure Global Gastrointestinal Cancer Drugs Sales Market Share by Product in 2018
Table Global Gastrointestinal Cancer Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Gastrointestinal Cancer Drugs Revenue Share by Product (2014-2019)
Figure Global Gastrointestinal Cancer Drugs Revenue Market Share by Product (2014-2019)
Figure Global Gastrointestinal Cancer Drugs Revenue Market Share by Product in 2018
Table Gastrointestinal Cancer Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Gastrointestinal Cancer Drugs Sales by End User (2014-2019) (K Units)
Table Global Gastrointestinal Cancer Drugs Sales Share by End User (2014-2019)
Figure Global Sales Gastrointestinal Cancer Drugs Market Share by End User (2014-2019)
Figure Global Sales Gastrointestinal Cancer Drugs Market Share by End User in 2018
Figure North America Gastrointestinal Cancer Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Gastrointestinal Cancer Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Gastrointestinal Cancer Drugs Sales by Countries (2014-2019) (K Units)
Table North America Gastrointestinal Cancer Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Gastrointestinal Cancer Drugs Sales Market Share by Countries
Table North America Gastrointestinal Cancer Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Gastrointestinal Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Gastrointestinal Cancer Drugs Revenue Market Share by Countries
Figure United States Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Gastrointestinal Cancer Drugs Sales by Product (2014-2019) (K Units)
Table North America Gastrointestinal Cancer Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Gastrointestinal Cancer Drugs Market Share by Product
Table North America Gastrointestinal Cancer Drugs Sales by End User (2014-2019) (K Units)
Table North America Gastrointestinal Cancer Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Gastrointestinal Cancer Drugs Market Share by End User
Figure Europe Gastrointestinal Cancer Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Gastrointestinal Cancer Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Gastrointestinal Cancer Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Gastrointestinal Cancer Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Gastrointestinal Cancer Drugs Sales Market Share by Countries
Table Europe Gastrointestinal Cancer Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Gastrointestinal Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Gastrointestinal Cancer Drugs Revenue Market Share by Countries
Figure Germany Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Gastrointestinal Cancer Drugs Sales by Product (2014-2019) (K Units)
Table Europe Gastrointestinal Cancer Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Gastrointestinal Cancer Drugs Market Share by Product
Table Europe Gastrointestinal Cancer Drugs Sales by End User (2014-2019) (K Units)
Table Europe Gastrointestinal Cancer Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Gastrointestinal Cancer Drugs Market Share by End User
Figure Asia Pacific Gastrointestinal Cancer Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Gastrointestinal Cancer Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Gastrointestinal Cancer Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Gastrointestinal Cancer Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Gastrointestinal Cancer Drugs Sales Market Share by Countries
Table Asia Pacific Gastrointestinal Cancer Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Gastrointestinal Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Gastrointestinal Cancer Drugs Revenue Market Share by Countries
Figure China Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Gastrointestinal Cancer Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Gastrointestinal Cancer Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Gastrointestinal Cancer Drugs Market Share by Product
Table Asia Pacific Gastrointestinal Cancer Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Gastrointestinal Cancer Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Gastrointestinal Cancer Drugs Market Share by End User
Figure Central & South America Gastrointestinal Cancer Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Gastrointestinal Cancer Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Gastrointestinal Cancer Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Gastrointestinal Cancer Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Gastrointestinal Cancer Drugs Sales Market Share by Countries
Table Central & South America Gastrointestinal Cancer Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Gastrointestinal Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Gastrointestinal Cancer Drugs Revenue Market Share by Countries
Figure Brazil Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Gastrointestinal Cancer Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Gastrointestinal Cancer Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Gastrointestinal Cancer Drugs Market Share by Product
Table Central & South America Gastrointestinal Cancer Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Gastrointestinal Cancer Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Gastrointestinal Cancer Drugs Market Share by End User
Figure Middle East and Africa Gastrointestinal Cancer Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Gastrointestinal Cancer Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Gastrointestinal Cancer Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Gastrointestinal Cancer Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Gastrointestinal Cancer Drugs Sales Market Share by Countries
Table Middle East and Africa Gastrointestinal Cancer Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Gastrointestinal Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Gastrointestinal Cancer Drugs Revenue Market Share by Countries
Figure GCC Countries Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Gastrointestinal Cancer Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Gastrointestinal Cancer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Gastrointestinal Cancer Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Gastrointestinal Cancer Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Gastrointestinal Cancer Drugs Market Share by Product
Table Middle East and Africa Gastrointestinal Cancer Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Gastrointestinal Cancer Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Gastrointestinal Cancer Drugs Market Share by End User
Table Amgen Limited & Amgen Ireland Limited Company Details
Table Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Limited & Amgen Ireland Limited Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly and Company Recent Development
Table Johnson & Johnson Private Limited Company Details
Table Johnson & Johnson Private Limited Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Private Limited Recent Development
Table GlaxoSmithKline plc. Company Details
Table GlaxoSmithKline plc. Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline plc. Recent Development
Table Celgene Corporation Company Details
Table Celgene Corporation Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Celgene Corporation Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Inc. Recent Development
Table Sanofi Company Details
Table Sanofi Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Novartis AG Company Details
Table Novartis AG Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis AG Recent Development
Table Global Gastrointestinal Cancer Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Gastrointestinal Cancer Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Gastrointestinal Cancer Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Gastrointestinal Cancer Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Gastrointestinal Cancer Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Gastrointestinal Cancer Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Gastrointestinal Cancer Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Gastrointestinal Cancer Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Gastrointestinal Cancer Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Gastrointestinal Cancer Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Gastrointestinal Cancer Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Gastrointestinal Cancer Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Gastrointestinal Cancer Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Gastrointestinal Cancer Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Gastrointestinal Cancer Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Gastrointestinal Cancer Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Gastrointestinal Cancer Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Gastrointestinal Cancer Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Gastrointestinal Cancer Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Gastrointestinal Cancer Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Gastrointestinal Cancer Drugs Value Chain
Table Gastrointestinal Cancer Drugs Customers List
Table Gastrointestinal Cancer Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
胃腸癌治療の世界市場：市場規模・現状・予測 Gastrointestinal Cancer Devices are various devices used to cure gastrointestinal cancer.Rise in incidences of lymphoma, adenocarcinoma, and gastrointestinal stromal tumors, increase in regulatory approvals for metastatic gastric cancer, low dose radiation technology based devices, and increase in n…- 前立腺癌治療薬の世界市場：市場規模・現状・予測 Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-MRI) can significantly improve the detection of tumor and also provide confirmation whether there is a need for tissue biopsy. In addition, market players ar…
- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …
- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …
- 腎臓癌治療薬の世界市場：市場規模・現状・予測 Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer.Market growth is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rise in incidence of renal cancer due to growing geriatric population and more prominent smoking habits. In 2018, the gl…